1*10^13 GC
Trade Name
Hemgenix
Concentrate for solution for infusion
Request Type
New Registration
Drug Type
Biological
Approval Date
SFDA Approved Use
Indicated for the treatment of severe and moderately severe Haemophilia B (congenital Factor IX deficiency) in adult patients without a history of Factor IX inhibitors.